BIBLIOGRAPHIC RECORD

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Manuel Romero‐Gómez; Eric Lawitz; R. Ravi Shankar; Eirum Chaudhri; Jie Liu; Raymond L. H. Lam; Keith D. Kaufman; Samuel S. Engel; Santiago Bruzone; Maria Jimena Coronel; Fernando Gruz; Ignacio J. Mackinnon; Jacob George; Kate Muller; Samuel S. Lee; Cyrielle Caussy; Jean‐Michel Petit; Ziv Ben Ari; Marius Braun; Helena Katchman; Yoav Lurie; Ella Veitsman; Eli Zuckerman; Alessio Aghemo; Stefania Basili; Anna Ludovica Fracanzani; Antonello Pietrangelo; David Sacerdoti; Jose Francisco Rubio Arce; A. Cetina
Source of metadata
OpenAlex
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Manuel Romero‐Gómez; Eric Lawitz; R. Ravi Shankar; Eirum Chaudhri; Jie Liu; Raymond L. H. Lam; Keith D. Kaufman; Samuel S. Engel; Santiago Bruzone; Maria Jimena Coronel; Fernando Gruz; Ignacio J. Mackinnon; Jacob George; Kate Muller; Samuel S. Lee; Cyrielle Caussy; Jean‐Michel Petit; Ziv Ben Ari; Marius Braun; Helena Katchman; Yoav Lurie; Ella Veitsman; Eli Zuckerman; Alessio Aghemo; Stefania Basili; Anna Ludovica Fracanzani; Antonello Pietrangelo; David Sacerdoti; Jose Francisco Rubio Arce; A. Cetina. (2023). A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. https://openalex.org/W4381803348

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-bc582b42c796f3b3b4b59df19005e487/